Document is current
Any future updates will be listed below
-
Authors
Karabulut, Yusuf https://orcid.org/0000-0003-2690-6196
Gezer, Halise Hande https://orcid.org/0000-0001-8790-304X
Esen, Selin https://orcid.org/0000-0002-3426-9505
Esen, İrfan
Türkoğlu, Ali Rıza https://orcid.org/0000-0003-0928-8269
- License Information
-
More Information
Article History
Received: 27 January 2022
Accepted: 31 March 2022
First Online: 25 April 2022
Declarations
:
: Dr. Yusuf Karabulut has received honoraria from AbbVie, UCB, Novartis, Pfizer and Lilly. The authors have no other relevant affiliation or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. All co-authors are aware of your journal’s conflict-of-interest policy; none of the co-authors has any direct or indirect conflicts of interest, financial or otherwise, relating to the subject of our report.
: The study protocol was approved by the Committee on Human Research Ethics of Ankara City Hospital (dated: 05.26.2021 decision number: E1-21-1663).
: All authors contributed significantly and consented for publication of the submitted version of the manuscript.
: Current study conducted retrospectively and Informed consent was not obtained.
